One of the most important names in this earnings season is the investment giant JP Morgan. The company released its results before the market open, and pre-market price moves have been minimal.
The market had very high expectations for the company, and the tough comparison base didn’t make it any easier to meet them. Still, in the end, the company managed to deliver another record quarter.
- Revenue exceeded USD 50 billion versus expectations of USD 49.2 billion. Including:
- FICC and trading: up 21% y/y, to USD 7 billion. Expectations were around USD 6.65 billion.
- Investment banking: up 38% y/y to USD 3.14 billion.
- Advisory: up 82% y/y to USD 1.27 billion.
- EPS: USD 5.94, versus expectations of about USD 5.45.
- Assets:
- Deposits: USD 2.68 trillion
- Loans: USD 1.5 trillion
- Net interest margin (NIM): 2.5% versus the expected 2.57%
So why doesn’t the stock price seem to be reacting to results that look phenomenal at first glance? Above all, despite strong revenue and profit, the net interest margin (NIM), a metric shareholders and the market consider crucial, came in slightly below expectations. In addition, the company lowered its full-year net interest income guidance from USD 104.5 billion to USD 103 billion. This means that despite beating revenue expectations, the core of the company’s business weakened slightly, but measurably.
Beyond the company’s numbers, the market also weighed every word from the firm’s legendary CEO, James Dimon. He managed to reassure part of the market that has real concerns about the consumer’s future condition and risks stemming from the PE/PC market. Dimon clearly confirmed that current volatility is benefiting the company, the consumer remains strong overall, and the U.S. economy and growth remain resilient—however, he pointed out that complex and real risks are being created by the situation in the commodities market and the war in Iran.
JPM.US (D1)
Despite recent declines driven by concerns surrounding PE/PC, the stock maintains a long-term, clearly defined uptrend. Source: xStation5
Daily Summary: U.S. stock indices are climbing following the PPI data
AI needs power and that’s where the profits are. Oracle and Bloom set the path.
US OPEN: Wall Street Rallies on Soft PPI Data
Novo Nordisk announces a strategic partnership with OpenAI🧬🤖
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
